p53 Induction by tumor necrosis factor-α and involvement of p53 in cell death of human oligodendrocytes

Journal of Neurochemistry

Volumn 73, Issue 2, 1999, Pages 605-611

  Ladiwala, Uma ^a   Li, Hewei ^a   Antel, Jack P ^a   Nalbantoglu, Josephine ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Adenovirus; Apoptosis; P53; Tumor necrosis factor Oligodendrocytes

Indexed keywords

DNA; LACTATE DEHYDROGENASE; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ADULT; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL NUCLEUS; CONTROLLED STUDY; DNA CLEAVAGE; FETUS; GENE INDUCTION; GENE OVEREXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OLIGODENDROGLIA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADULT; APOPTOSIS; BRAIN; CELLS, CULTURED; FETUS; GENE EXPRESSION REGULATION, VIRAL; GENE TRANSFER TECHNIQUES; HUMANS; IN SITU NICK-END LABELING; LAC OPERON; OLIGODENDROGLIA; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53;

ADENOVIRIDAE;

EID: 0032777902     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0730605.x     Document Type: Article

References (42)

1. Acsadi G., Jani A., Massie B., Simoneau M., Holland P., Blaschuk K., and Karpati G. (1994) A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum. Mol. Genet. 3, 579-584.
2. Baker S. J. and Reddy E. P. (1996) Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12, 1-9.
3. Beg A. A. and Baltimore D. (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784.
4. Beidler D. R., Tewari M., Friesen P. D., Poirier G., and Dixit V. M. (1995) The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 270, 16526-16528.
5. Calles C., Helmberg A., and Karin M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370, 220-223.
6. Chen L., Maréchal V., Moreau J., Levine A. J., and Chen J. (1997) Proteolytic cleavage of the mdm2 oncoprotein during apoptosis. J. Biol. Chem. 272, 22966-22973.
7. D'Souza S., Alinaukas K., McCrae E., Goodyer C., and Antel J. P. (1995) Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J. Neurosci. 15, 7293-7300.
8. D'Souza S. D., Bonetti B., Balasingam V., Cashman N. R., Barker P. A., Troutt A. B., Raine C. S., and Antel J. P. (1996) Multiple sclerosis: fas signalling in oligodendrocyte cell death. J. Exp. Med. 184, 2361-2370.
9. Eizenberg O., Faber-Elman A., Gottlieb E., Oren M., Rotter V., and Schwartz M. (1995) Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J. 14, 1136-1144.
10. Erhardt P., Tomaselli K. J., and Cooper G. M. (1997) Identification of the mdm2 oncoprotein as a substrate for CPP32-like apoptotic proteases. J. Biol. Chem. 272, 15049-15052.
11. Friedlander P., Haupt Y., Prives C., and Oren M. (1996) A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol. 16, 4961-4971.
12. Fuchs S. Y., Adler V., Pincus M. R., and Ronai Z. (1998) MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. USA 95, 10541-10546.
13. Gottlieb W. H., Watson J. M., Rezai A., Johnson M., Martinez-Maza O., and Berek J. S. (1994) Cytokine-induced modulation of tumor suppressor gene expression in ovarian cancer cells: up-regulation of p53 gene expression and induction of apoptosis by tumor necrosis factor-alpha. Am. J. Obstet. Gynecol. 170, 1121-1130.
14. Harris C. C. (1996) Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. Natl. Cancer Inst. 88, 1442-1455.
15. Haupt Y., Rowan S., Shaulian E., Vousden K. H., and Oren M. (1995) Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev. 9, 2170-2183.
16. Hecker D., Page G., Lohrum M., Weiland S., and Scheidtmann K. H. (1996) Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs. Oncogene 12, 953-961.
17. Hu M. C. T., Qiu W. R., and Wang Y. P. (1997) JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases. Oncogene 15, 2277-2287.
18. Jaattela M., Benedict M., Tewari M., Shayman J. A., and Dixit V. M. (1995) Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10, 2297-2305.
19. Kayatose D., Gudas J., Nguyen H., Srivastava S., Cowan K., and Seth P. (1995) Cytotoxic effects of adenovirus-mediated wild type p53 protein expression in normal and tumor mammary epithelial cells. Clin. Cancer Res. 1, 889-897.
20. Ladiwala U., Lachance C., Simoneau S. J., Bhakar A., Barker P. A., and Antel J. P. (1998) p75 neurotrophin receptor expression on adult human oligodendrocytes: signaling without death in response to NGF. J. Neurosci. 18, 1297-1304.
21. Levine A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
22. Li Y., Chopp M., Zhang Z. G., Zaloga C., Niewenhuis L., and Gautam S. (1994) p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke 25, 849-855.
23. Liu Z., Hsu H., Goeddel D. V., and Karin M. (1996) Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87, 565-576.
24. Lochmüller H., Jani A., Huard J., Prescott S., Simoneau M., Massie B., Karpati G., and Acsadi G. (1994) Emergence of early region 1 (E1)-containing replication competent adenovirus in stocks of replication defective adenovirus recombinants (ΔE1 + ΔE3) during multiple passages in 293 cells. Hum. Gene Ther. 5, 1485-1491.
25. Ludwig R. L., Bates S., and Vousden K. H. (1996) Differential activation of target cellular promoters by p53 mutants impairs apoptotic function. Mol. Cell. Biol. 16, 4952-4960.
26. 2 terminus of p53 facilitates transactivation. Cancer Res. 55, 2410-2417.
27. Milne D. W., Campbell L. E., Campbell D. G., and Meek D. W. (1995) p53 phosphorylation in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-jun kinase, JNK1. J. Biol. Chem. 270, 5511-5518.
28. Miyashita T. and Reed J. C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
29. Miyashita T., Krajewski S., Krajewska M., Wang H. G., Lin H. K., Lieberman D. A., Hoffman B., and Reed J. C. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799-1805.
30. Nagata S. (1997) Apoptosis by death factor. Cell 88, 355-356.
31. Owen-Schaub L. B., Zhang W., Cusack J. C., Angelo L. S., Santee S. M., Fujiwara T., Roth J. A., Deisseroth A. B., Zhang W. W., Kruzel E., and Radinsky R. (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/Apo-1 expression. Mol. Cell. Biol. 15, 3032-3040.
32. Ozawa K., Suchanek G., Breitschopf H., Bruck W., Budka H., Jellinger K., and Lassmann H. (1994) Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117, 1311-1322.
33. Piette J., Neel H., and Maréchal V. (1997) Mdm2: keeping p53 under control. Oncogene 15, 1001-1010.
34. Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., and Kollias K. (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumour necrosis factor alpha. Proc. Natl. Acad. Sci. USA 92, 11294-11298.
35. Raine C. S. (1990) Demyelinating disease, in Textbook of Neuroparhology (Davis R. L. and Robertson D. M., eds), pp. 535-620. Williams & Wilkins, Baltimore.
36. Sakhi S., Bruce A., Sun N., Tocco G., Baudry M., and Schreiber S. S. (1997) Induction of tumor suppressor p53 and DNA fragmentation in organotypic hippocampal cultures following excitotoxin treatment. Exp. Neurol. 145, 81-88.
37. Selmaj K. W., Raine C. S., Canella B., and Brosnan C. (1991) Identification of lymphotoxin and tumour necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
38. Seto E., Usheva A., Zambetti G. P., Momand J., Horikoshi N., Weinmann R., Levine A. J., and Shenk T. (1992) Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA 89, 12028-12032.
39. Tamura T., Aoyama N., Saya H., Haga H., Futami S., Miyamoto M., Koh T., Ariyasu T., Tachi M., Kasuga M., and Takahashi R. (1995) Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene 11, 1939-1946.
40. Taupin V., Renno T., Bourbonnière L., Peterson A. C., Rodriguez M., and Owens T. (1997) Increased severity of experimental autoimmune encephalitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-α in the central nervous system. Eur. J. Immunol. 27, 905-913.
41. Yong V. W. and Antel J. P. (1992) Culture of glial cells from human biopsies, in Protocols for Neural Cell Culture (Richardson A. and Federoff S., eds), pp. 81-86. Humana Press, St. Louis.
42. Zhang P., Miller B. S., Rosenzweig S. A., and Bhat N. R. (1996) Activation of c-jun N-terminal kinase/stress-activated protein kinase in primary glial cultures. J. Neurosci. Res. 46, 114-121.